Ortho Phthalaldehyde Global Market Report 2026

Ortho phthalaldehyde (OPA) is an aromatic chemical compound widely used as a high-level disinfectant, especially for medical and laboratory instruments. It is effective against a broad spectrum of microorganisms, including bacteria, viruses, and mycobacteria, even at low concentrations. OPA is appreciated for its fast action and chemical stability, although it can lead to skin or respiratory irritation with extended exposure.

The primary product types of ortho phthalaldehyde include liquid ortho-phthalaldehyde (OPA) and powder ortho-phthalaldehyde (OPA). Liquid ortho-phthalaldehyde refers to a ready-to-use high-level disinfectant formulation that is extensively utilized in healthcare environments for fast and efficient microbial elimination. It is classified based on purity levels, including greater than or equal to ninety-nine percent and less than ninety-nine percent, and is supplied through direct sales, distributors and wholesalers, online medical supply platforms, and various other distribution channels. Its applications span endoscope reprocessing and disinfection, medical device sterilization, hospital surface sanitation, laboratory equipment sterilization, and dialysis equipment cleaning and disinfection, and it is adopted by multiple end users such as hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, research institutes, and pharmaceutical and biotechnology companies.

Tariffs are influencing the ortho phthalaldehyde market by raising the cost of imported raw chemicals, specialty intermediates, and medical-grade formulation equipment used in disinfectant manufacturing. This is impacting key segments such as Liquid Ortho-Phthalaldehyde (OPA) and Powder Ortho-Phthalaldehyde (OPA), along with applications including endoscope reprocessing, medical device sterilization, and hospital surface disinfection. Regions such as Asia-Pacific and Europe are most impacted due to reliance on imported healthcare chemicals and strict infection control requirements across large hospital networks. However, tariffs are also driving localized production of medical disinfectants, strengthening regional supply chains, and encouraging investment in domestic healthcare chemical manufacturing capabilities, thereby enhancing long-term supply security.

The ortho phthalaldehyde market research report is one of a series of new reports from The Business Research Company that provides ortho phthalaldehyde market statistics, including ortho phthalaldehyde industry global market size, regional shares, competitors with a ortho phthalaldehyde market share, detailed ortho phthalaldehyde market segments, market trends and opportunities, and any further data you may need to thrive in the ortho phthalaldehyde industry. This ortho phthalaldehyde market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ortho phthalaldehyde market size has grown strongly in recent years. It will grow from $4.18 billion in 2025 to $4.42 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing hospital-acquired infection concerns, expansion of healthcare infrastructure, growth in surgical and diagnostic procedures, rising demand for high-level disinfectants in medical settings, adoption of chemical sterilization in laboratory environments.

The ortho phthalaldehyde market size is expected to see strong growth in the next few years. It will grow to $5.6 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing regulatory standards for infection control, rising demand for minimally toxic disinfectants, growth in outpatient surgical procedures, expansion of biotechnology and diagnostic laboratories, increasing focus on advanced hospital hygiene systems. Major trends in the forecast period include rising demand for high-level disinfectants in endoscope reprocessing workflows, increasing adoption of rapid-acting sterilants for hospital infection control, expansion of automated disinfection systems in diagnostic laboratories, shift toward low-residue chemical disinfectants for medical device safety, growing preference for stable high-efficacy aldehyde-based sterilization solutions.

The rising prevalence of hospital-acquired infections is anticipated to drive the growth of the ortho phthalaldehyde market going forward. Hospital-acquired infections (HAIs) refer to infections that patients contract during the course of receiving medical care in a healthcare facility, which are neither present nor incubating at the time of admission. The increasing incidence of hospital-acquired infections is attributed to the excessive use of invasive medical devices, which create direct entry routes for pathogens to penetrate the body and establish infections. Ortho-phthalaldehyde, functioning as a high-level disinfectant, aids in minimizing hospital-acquired infections by efficiently destroying a wide range of pathogens on medical instruments and surfaces used in clinical environments. For instance, in May 2024, according to the Center for Infectious Disease Research and Policy (CIDRAP), a US-based disease research organization, the number of patients acquiring at least one healthcare-acquired infection in hospitals across the European Union and European Economic Area was nearly 4.3 million per year in 2022 and 2023. Therefore, the rising prevalence of hospital-acquired infections is driving the growth of the ortho phthalaldehyde market.

The increasing number of surgical procedures is anticipated to propel the growth of the ortho phthalaldehyde market going forward. Surgical procedures are medical interventions that utilize manual or instrumental techniques to diagnose, treat, or manage diseases, injuries, or deformities by cutting, removing, repairing, or replacing body tissues. The rise in surgical procedures is driven by the growing prevalence of chronic diseases, which frequently advance to severe stages requiring surgical intervention for effective treatment and improved patient outcomes. Ortho-phthalaldehyde (OPA) supports surgical procedures by enabling high-level disinfection of critical medical instruments such as endoscopes and surgical tools, ensuring they remain free from harmful microorganisms. For instance, in February 2025, according to the 2024 annual report by Intuitive Surgical Inc., a US-based medical device company, approximately 2,683,000 surgical procedures were performed using da Vinci surgical systems, rising from around 2,286,000 procedures in 2023 and 1,875,000 procedures in 2022, reflecting consistent year-over-year growth in utilization. Therefore, the increasing number of surgical procedures is driving the growth of the ortho phthalaldehyde market.

The expanding geriatric population is expected to propel the growth of the ortho phthalaldehyde market going forward. The geriatric population refers to individuals aged 65 years and older who are more vulnerable to chronic health conditions due to age-related physiological changes. The growth in the geriatric population is driven by increasing life expectancy and declining birth rates, resulting in a larger proportion of older individuals within the total population. Ortho phthalaldehyde supports the geriatric population by facilitating rapid and effective high-level disinfection of medical instruments, thereby lowering the risk of healthcare-associated infections in elderly patients with weakened immune systems. For instance, in February 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, the global population of people aged 60 years and above is increasing rapidly due to longer life expectancy and declining birth rates, with older adults expected to surpass younger age groups in many regions by 2030. Therefore, the growing geriatric population is driving the growth of the ortho phthalaldehyde market.

Major companies operating in the ortho phthalaldehyde market are Thermo Fisher Scientific Inc., Merck KGaA, MP Biomedicals LLC, Simson Pharma Limited, Shodhana Laboratories Pvt. Ltd., Spectrum Chemical Manufacturing Corp., Otto Chemie Pvt. Ltd., Garonit Pharmaceutical, TCI Chemicals (India) Pvt. Ltd., Unilab Chemicals & Pharmaceuticals Pvt. Ltd., Loba Chemie Pvt. Ltd., Muby Chemicals, Freesia Chemicals, Microwin Labs Private Limited, Benzo Chem Industries Pvt. Ltd., N S Chemicals and Consultants Pvt. Ltd., Super Hygienic Chemicals, Affinity Specialty Chemicals, Ebele Cosmeceuticals, RYZE Chemie

North America was the largest region in the ortho phthalaldehyde market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ortho phthalaldehyde market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ortho phthalaldehyde market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ortho phthalaldehyde market consists of sales of high-level disinfectant solutions for medical instruments, hospital-grade surface disinfection products, and laboratory and diagnostic equipment cleaning agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ortho Phthalaldehyde Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ortho phthalaldehyde market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ortho phthalaldehyde ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ortho phthalaldehyde market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Liquid Ortho-Phthalaldehyde (OPA); Powder Ortho-Phthalaldehyde (OPA)
• 2) By Purity: Greater Than Or Equal To Ninety-Nine Percent; Less Than Ninety-Nine Percent
• 3) By Distribution Channel: Direct Sales; Distributors And Wholesalers; Online Medical Supply Platforms; Other Distribution Channel
• 4) By Application: Endoscope Reprocessing And Disinfection; Medical Device Sterilization; Hospital Surface Disinfection; Laboratory Equipment Sterilization; Dialysis Equipment Cleaning And Disinfection
• 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Ambulatory Surgical Centers; Research Institutes; Pharmaceutical And Biotechnology Companies
• Subsegments:
• 1) By Liquid Ortho-Phthalaldehyde (OPA): Ready To Use Solutions; Concentrated Liquid Solutions; Hospital Grade Liquid Solutions; Laboratory Grade Liquid Solutions
• 2) By Powder Ortho-Phthalaldehyde (OPA): Fine Powder Formulations; Granular Powder Formulations; Industrial Grade Powder; Pharmaceutical Grade Powder
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; MP Biomedicals LLC; Simson Pharma Limited; Shodhana Laboratories Pvt. Ltd.; Spectrum Chemical Manufacturing Corp.; Otto Chemie Pvt. Ltd.; Garonit Pharmaceutical; TCI Chemicals (India) Pvt. Ltd.; Unilab Chemicals & Pharmaceuticals Pvt. Ltd.; Loba Chemie Pvt. Ltd.; Muby Chemicals; Freesia Chemicals; Microwin Labs Private Limited; Benzo Chem Industries Pvt. Ltd.; N S Chemicals and Consultants Pvt. Ltd.; Super Hygienic Chemicals; Affinity Specialty Chemicals; Ebele Cosmeceuticals; RYZE Chemie
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.